Innovation Pharmaceuticals Inc (IPIX)

[roiresearch]

Thanks. I assume upcoming keys to look for in PR's this month

1) cdmo update that we'll have 10,000 doses within 6 months
2) in vivo efficacy data

I would assume that if the RBL and/or PHRI have submitted for federal funding at least one of the labs would have addressed 'in vivo'

or would previous data done for different indications possibly cover 'in vivo efficacy data"?

here is an overview of TRL 6